Literature DB >> 17067267

Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.

Rafael Contreras-Galindo1, Mark H Kaplan, David M Markovitz, Eric Lorenzo, Yasuhiro Yamamura.   

Abstract

Approximately 8% of the human genome sequence is composed by human endogenous retroviruses (HERVs), most of which are defective. HERV-K(HML-2) is the youngest and most active family and has maintained some proviruses with intact open reading frames (ORFs) that code for viral proteins that may assemble into viral particles. Many HERV-K(HML-2) sequences are polymorphic in humans (present in some individuals but not in others) and probably many others may be unfixed (not inserted permanently in a specific chromosomal location of the human genome). In the present study HIV-1 and HCV-1-positive plasma samples were screened for the presence of HERV-K(HML-2) RNA in an RT-PCR using HERV-K pol specific primers. HERV-K(HML-2) viral RNA sequences were found almost universally in HIV-1(+) plasma samples (95.33%) but were rarely detected in HCV-1 patients (5.2%) or control subjects (7.69%). Other HERV-K(HML-2) viral segments of the RNA genome including gag, prt, and both env regions, surface (su), and transmembrane (tm) were amplified from HERV-K pol-positive plasma of HIV-1 patients. Type 1 and type 2 HERV-K(HML- 2) viral RNA genomes were found to coexist in the same plasma of HIV-1 patients. These results suggest the HERV-K(HML-2) viral particles are induced in HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067267     DOI: 10.1089/aid.2006.22.979

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  56 in total

Review 1.  HIV reservoirs and strategies for eradication.

Authors:  Miranda Z Smith; Fiona Wightman; Sharon R Lewin
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

2.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.

Authors:  Ravi Tandon; Devi SenGupta; Lishomwa C Ndhlovu; Raphaella G S Vieira; R Brad Jones; Vanessa A York; Vinicius A Vieira; Elizabeth R Sharp; Andrew A Wiznia; Mario A Ostrowski; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Controversies in HIV cure research.

Authors:  Rowena Johnston; Françoise Barré-Sinoussi
Journal:  J Int AIDS Soc       Date:  2012-03-16       Impact factor: 5.396

5.  Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.

Authors:  Jonah B Sacha; In-Jeong Kim; Lianchun Chen; Jakir H Ullah; David A Goodwin; Heather A Simmons; Daniel I Schenkman; Frederike von Pelchrzim; Robert J Gifford; Francesca A Nimityongskul; Laura P Newman; Samantha Wildeboer; Patrick B Lappin; Daisy Hammond; Philip Castrovinci; Shari M Piaskowski; Jason S Reed; Kerry A Beheler; Tharsika Tharmanathan; Ningli Zhang; Sophie Muscat-King; Melanie Rieger; Carla Fernandes; Klaus Rumpel; Joseph P Gardner; Douglas H Gebhard; Juliann Janies; Ahmed Shoieb; Brian G Pierce; Dusko Trajkovic; Eva Rakasz; Sing Rong; Michael McCluskie; Clare Christy; James R Merson; R Brad Jones; Douglas F Nixon; Mario A Ostrowski; Peter T Loudon; Ingrid M Pruimboom-Brees; Neil C Sheppard
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

6.  HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.

Authors:  Laurie R Gray; Rachel E Jackson; Patrick E H Jackson; Stefan Bekiranov; David Rekosh; Marie-Louise Hammarskjöld
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

7.  Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Angie C Contreras-Galindo; Marta J Gonzalez-Hernandez; Ilaria Ferlenghi; Fabiola Giusti; Eric Lorenzo; Scott D Gitlin; Michael H Dosik; Yasuhiro Yamamura; David M Markovitz
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

8.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

9.  Structural Mimicry Drives HIV-1 Rev-Mediated HERV-K Expression.

Authors:  Ina P O'Carroll; Lixin Fan; Tomáš Kroupa; Erin K McShane; Christophe Theodore; Elizabeth A Yates; Benjamin Kondrup; Jienyu Ding; Tyler S Martin; Alan Rein; Yun-Xing Wang
Journal:  J Mol Biol       Date:  2020-11-14       Impact factor: 5.469

10.  Development of a novel one-tube isothermal reverse transcription thermophilic helicase-dependent amplification platform for rapid RNA detection.

Authors:  James Goldmeyer; Huimin Kong; Wen Tang
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.